Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 3 Turcot syndrome 2 Medulloblastoma 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Rhabdoid Tumor 1 Recurrence 1 Rectal Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Pinealoma 1 Peutz-Jeghers Syndrome 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Mouth Neoplasms 1 Locally Advanced Rectal Cancer 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Ependymoma 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Adenomatous Polyposis Coli 1

Interventions

Injections 6 Fluorodeoxyglucose F18 4 Cyclophosphamide 4 Bevacizumab 4 toripalimab 3 fludarabine 2 Specimen Handling 2 Nivolumab 2 zimberelimab 1 tumor-cells apoptosis factor, human 1 trametinib 1 tislelizumab 1 temsirolimus 1 spartalizumab 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 etoposide phosphate 1 enzalutamide 1 envafolimab 1 donafenib 1 disitamab vedotin 1 dabrafenib 1 cemiplimab 1 avelumab 1 atezolizumab 1 anlotinib 1 WW Domain-Containing Oxidoreductase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Solid Tumor × Celecoxib × Clear all

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡